ArticleAesthetic surgery journal. Open forum2025
A Retrospective Evaluation of the Safety of Combining Helium-Based Plasma Radiofrequency Technology With Ultrasound-Assisted Lipoabdominoplasty.
Article in Aesthetic surgery journal. Open forum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- A Systematic Review of Helium Plasma Radiofrequency (Renuvion).Annals of plastic surgery · 2025Pooled it
- Helium Plasma Radiofrequency for Aesthetic Subdermal Treatment: A Systematic Review and Meta-Analysis.Aesthetic surgery journal. Open forum · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Helium plasma radiofrequency (RF; Renuvion; Apyx Medical, Clearwater, FL) is cleared for use in the coagulation/contraction of subcutaneous soft tissue, in body contouring, and to address loose skin in the neck and submental region. The device instantly heats target tissue to >85 °C, causing rapid protein coagulation within 0.04 s, resulting in tissue contraction. The use of multiple energy-based devices in lipoabdominoplasty is controversial. Objectives: To assess the safety of helium plasma RF as an adjunct to lipoabdominoplasty utilizing ultrasound-assisted liposuction (UAL; VASER, Solta Medical, Bothell, WA). Methods: In this retrospective, single-center study, medical records for patients who underwent UAL and abdominoplasty with or without helium-based plasma RF as an adjunct for subdermal coagulation between October 2017 and March 2023 were reviewed. Primary outcomes included significant and nonsignificant adverse events (AEs). Univariate and multivariate analyses were used to identify any risk factors for AEs. Results: A total of 40 patients treated with lipoabdominoplasty and helium plasma RF and 37 patients treated with lipoabdominoplasty alone were included in the analysis. Overall, no significant difference between groups was detected for the occurrence of significant AEs ( Conclusions: In this study, it is indicated that the helium plasma RF device may be a safe adjunct for UAL lipoabdominoplasty. When used for subdermal coagulation in the abdominal area, the device does not appear to increase the incidence of serious AEs or introduce risk to the flap. Level of Evidence 3 Therapeutic:
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.